⌘K

Home/Filings/4/A/0001437749-19-015541

4/A//SEC Filing

Adams Robert W 4/A

Accession 0001437749-19-015541

CIK 0001053691other

View on SEC.gov Company Profile

Filed

Aug 5, 8:00 PM ET

Accepted

Aug 6, 8:53 AM ET

Size

6.8 KB

Accession

0001437749-19-015541

Insider Transaction Report

Form 4/AAmended

Period: 2019-06-13

Diffusion Pharmaceuticals Inc.DFFN

Director

Transactions

Award
Stock Option (Right to Buy)
2019-06-13+19,200→ 19,200 total
Exercise: $3.15Exp: 2029-06-13→ Common Stock (19,200 underlying)

Holdings

Common Stock
2,337
Common Stock
(indirect: By 401(k))
1,260

Footnotes (1)

[F1]The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020.

Documents

1 file

4
rdgdoc.xml
FORM 4/A

Issuer

Diffusion Pharmaceuticals Inc.

CIK 0001053691

Entity typeother

Related Parties

1

filerCIK 0001663144

Filing Metadata

Form type: 4/A
Filed: Aug 5, 8:00 PM ET
Accepted: Aug 6, 8:53 AM ET
Size: 6.8 KB

View on SEC.gov